Management of Alcoholic Gastritis
Immediate and complete alcohol abstinence combined with proton pump inhibitor therapy forms the cornerstone of alcoholic gastritis management, supplemented by aggressive nutritional support and vitamin replacement. 1
Immediate Interventions
Alcohol Cessation
- Alcohol abstinence is the single most critical intervention and must be initiated immediately, as continued alcohol consumption perpetuates mucosal damage and inflammation. 1
- Implement brief alcohol intervention during the acute presentation, which reduces alcohol consumption by approximately 41 grams per week and is as effective as intensive treatments. 1
- Assess for alcohol withdrawal severity using standardized scoring systems, as withdrawal may require specific management protocols. 1
- Arrange extended alcohol counseling after discharge to maintain long-term abstinence. 1
Acid Suppression Therapy
- Prescribe proton pump inhibitors (PPIs) as first-line pharmacologic therapy to reduce gastric acid secretion and promote mucosal healing. 1
- Continue PPI therapy until mucosal healing is confirmed and symptoms resolve. 1
- PPIs are more effective than H2-receptor antagonists, which are superior to placebo for symptomatic relief. 1
- Do not use metoclopramide as monotherapy for GERD-like symptoms in alcoholic gastritis patients, as evidence shows it is ineffective. 1
Nutritional Management
Caloric and Protein Requirements
- Provide 35-40 kcal/kg/day with protein intake of 1.2-1.5 g/kg/day for all patients. 1
- For severely ill patients, increase protein intake to 1.5 g/kg/day. 1
- Consider enteral nutrition via nasogastric or nasoenteral tube if oral intake is inadequate. 1
Vitamin and Mineral Supplementation
- Administer thiamine 100-300 mg/day IV for 3-4 days to prevent Wernicke's encephalopathy, particularly before any glucose-containing solutions. 1
- Thiamine can be given orally or enterally in stable patients, though IV route is most efficient for acute deficiency. 1
- Supplement with B-complex vitamins (especially vitamin B12, folic acid, pyridoxine), vitamin A, vitamin D, vitamin E, and zinc. 1
- These micronutrient deficiencies are common in alcoholic patients and can worsen outcomes if left untreated. 1
Management of Complications
Gastrointestinal Bleeding
- For active bleeding related to alcoholic gastritis, perform endoscopic therapy as the primary intervention. 1
- Consider angiographic embolization techniques when endoscopy is not effective or feasible. 1
Symptom Control
- For nausea and vomiting, use dopamine receptor antagonists (prochlorperazine, haloperidol, metoclopramide). 1
- For persistent symptoms despite initial therapy, add 5-HT3 receptor antagonists or anticholinergic agents. 1
Helicobacter pylori Considerations
While not emphasized in current guidelines, research evidence suggests:
- H. pylori infection occurs in approximately 29-33% of alcoholics and is strongly associated with active chronic antral gastritis. 2, 3
- When H. pylori is present, triple therapy (bismuth subsalicylate, amoxicillin, and metronidazole) results in almost complete normalization of histologic findings and significant improvement in dyspeptic symptoms. 3
- Consider testing for H. pylori in patients with persistent symptoms despite standard therapy, as eradication improves both histological and symptomatic outcomes. 4, 3
Critical Pitfalls to Avoid
- Monitor closely for nutritional deficiencies, which are present in nearly all patients with severe alcohol-related conditions and significantly worsen outcomes. 1
- Be vigilant for signs of alcohol withdrawal, which may develop during hospitalization and require specific management. 1
- Recognize coexisting alcohol-related conditions, particularly alcoholic liver disease, which often accompanies alcoholic gastritis and requires additional management strategies. 1
- Do not assume symptoms will resolve with alcohol cessation alone—active pharmacologic and nutritional interventions are essential. 1
- Avoid nephrotoxic agents including diuretics during acute presentation, as they increase risk of acute kidney injury. 5
Long-Term Management
- Addiction treatment must be systematically offered after the acute episode to prevent recurrence. 6
- For alcohol-dependent patients without advanced liver disease, consider naltrexone or acamprosate combined with counseling to reduce relapse risk. 1
- Recommend complete abstinence, as even moderate continued alcohol consumption increases mortality risk in patients with established gastric or liver disease. 5
- Schedule follow-up to assess symptom resolution, confirm mucosal healing, and reinforce abstinence strategies. 1